Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Transplant Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00881582
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients

Who this might be right for
Chronic Hepatitis CRenal Transplant
King Abdulaziz Medical City 32
Testing effectiveness (Phase 2)Study completedNCT03629080
What this trial is testing

CMV Vaccine (HB-101) in Kidney Transplant Patients

Who this might be right for
Cytomegalovirus (CMV) InfectionKidney Transplantation
Hookipa Biotech GmbH 83
Testing effectiveness (Phase 2)UnknownNCT00644579
What this trial is testing

BLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients

Who this might be right for
Cutaneous Warts
NatImmune A/S 120
Not applicableLooking for participantsNCT07086989
What this trial is testing

Cardiovascular Risk in Children With Chronic Conditions Study

Who this might be right for
Kidney TransplantFamilial HypercholesterolaemiaType 1 Diabetes Mellitus (T1DM)+22 more
Semmelweis University 300
Post-approval studies (Phase 4)WithdrawnNCT03623568
What this trial is testing

Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant

Who this might be right for
Kidney FailureKidney DiseasesHepatitis C
Raymond T. Chung, MD
Not applicableStudy completedNCT00682045
What this trial is testing

Latent Tuberculosis Infection in Renal Transplant Recipients

Who this might be right for
Renal Transplant
Asan Medical Center 240
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Not applicableStudy completedNCT05756036
What this trial is testing

Torque Teno Virus: A Biomarker of Immunosuppression

Who this might be right for
Renal Transplant RejectionImmunosuppressionRenal Transplant Failure+1 more
Queen Mary University of London 268
Early research (Phase 1)Active Not RecruitingNCT03816332
What this trial is testing

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more
National Cancer Institute (NCI) 12
Not applicableUnknownNCT05081141
What this trial is testing

HHV8 and Solid Organ Transplantation

Who this might be right for
HHV8HHV8 InfectionHHV8-Related Malignant Neoplasm+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 250
Not applicableLooking for participantsNCT06243731
What this trial is testing

Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Who this might be right for
Cytomegalovirus (CMV)Kidney DiseaseKidney Failure
Takeda 10
Testing effectiveness (Phase 2)Looking for participantsNCT07368153
What this trial is testing

Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors

Who this might be right for
EBV InfectionsKidney Transplant
University Hospital, Basel, Switzerland 9
Large-scale testing (Phase 3)Study completedNCT04129398
What this trial is testing

MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)

Who this might be right for
Cytomegalovirus InfectionCytomegalovirus Disease
Merck Sharp & Dohme LLC 22
Not applicableStudy completedNCT01883206
What this trial is testing

CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response

Who this might be right for
Viraemia
University College, London 48
Not applicableEnded earlyNCT02064699
What this trial is testing

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.

Who this might be right for
Renal Transplant RecipientImmunized Against the Cytomegalovirus
University Hospital, Limoges 75
Not applicableLooking for participantsNCT06538961
What this trial is testing

Immune Registry for BK in Kidney Transplant Recipients

Who this might be right for
BK Virus InfectionKidney Transplant; Complications
Virginia Commonwealth University 60
Post-approval studies (Phase 4)WithdrawnNCT04614142
What this trial is testing

Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access

Who this might be right for
End Stage Renal DiseaseChronic Hepatitis c
Massachusetts General Hospital
Post-approval studies (Phase 4)Looking for participantsNCT07266467
What this trial is testing

Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
First Affiliated Hospital Xi'an Jiaotong University 290
Not applicableLooking for participantsNCT04526431
What this trial is testing

Tacrolimus Pharmacokinetic Subpopulations

Who this might be right for
Kidney Transplant Failure and RejectionImmunosuppression-related Infectious Disease
University Hospital, Grenoble 180
Not applicableStudy completedNCT04874740
What this trial is testing

Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region

Who this might be right for
COVID-19 PandemicTransplantation, Kidney
University Hospital Ostrava 300
Next Page